Financial & Business News
LATEST INVESTING HEADLINES
NEW YORK, NY / ACCESS Newswire / January 28, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=125641&wire=1 or contact Joseph E. Levi, Esq.
Oil prices steadied on Wednesday as investors weighed the impact of potential U.S. tariffs on Canadian and Mexican imports, while largely shrugging off an increase in U.S. weekly crude inventory.
LendingClub's latest quarterly results, released Tuesday (Jan. 28), indicated growth across several key metrics, including loan originations and deposits through its digital banking arm, and some improving credit metrics. However, in some cases, growth decelerated in the final quarter of the year, and forward-looking guidance helped send shares down 23% after hours on Tuesday.
SoftBank is negotiating a $500 million investment in Skild AI, a software company building a foundational model for robotics at a $4 billion valuation, Bloomberg and Financial Times reported.
F5, Inc. (NASDAQ:FFIV ) Q1 2025 Earnings Conference Call January 28, 2025 4:30 PM ET Company Participants Suzanne DuLong - VP, IR Francois Locoh-Donou - President and CEO Cooper Werner - EVP and CFO Conference Call Participants Tim Long - Barclays Meta Marshall - Morgan Stanley Samik Chatterjee - JPMorgan Michael Ng - Goldman Sachs Tal Liani - Bank of America Amit Daryanani - Evercore ISI Matthew Hedberg - RBC James Fish - Piper Sandler Victor Chiu - Raymond James Matt Dezort - Needham & Company Sebastien Naji - William Blair Operator Good afternoon, and welcome to the F5, Inc. First Quarter Fiscal 2025 Financial Results Conference Call. [Operator Instructions] Also, today's conference is being recorded.
SAN MATEO, Calif. & TOKYO--(BUSINESS WIRE)--Sony Group Corporation and Sony Interactive Entertainment (SIE), the company behind PlayStation, today announced the appointment of Hideaki Nishino to the role of President and CEO effective April 1, 2025. This marks an evolution designed to maximize synergies across SIE that was announced in May 2024 in which Nishino was appointed CEO of the Platform Business Group effective June 1, 2024, alongside Hermen Hulst, who was appointed CEO of the Studio Bu.
Hanmi Financial Corporation (NASDAQ:HAFC ) Q4 2024 Earnings Call Transcript January 28, 2025 5:00 PM ET Company Participants Ben Brodkowitz - IR, Financial Profiles, Inc. Bonnie Lee - President and Chief Executive Officer Anthony Kim - Senior Executive Vice President and Chief Banking Officer Ron Santarosa - Senior Executive Vice President and Chief Financial Officer Conference Call Participants Matthew Clark - Piper Sandler Ahmad Hasan - DA Davidson Matthew Erdner - JonesTrading Operator Ladies and gentlemen, welcome to Hanmi Financial Corporation's Fourth Quarter and Full Year 2024 Conference Call. As a reminder, today's call is being recorded for replay purposes.
Perseus Mining Limited (OTCPK:PMNXF) December 2024 Quarter Earnings Conference Call January 28, 2025 5:00 PM ET Company Participants Nathan Ryan – Media Relations Jeff Quartermaine – Managing Director and Chief Executive Officer Lee-Anne de Bruin – Chief Financial Officer Conference Call Participants Kate McCutchen – Citi Levi Spry – UBS Richard Knights – Barrenjoey Nathan Ryan Good morning, and welcome to the Perseus Mining Investor Webinar and Conference Call. All attendees are in a listen-only mode.
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline.
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against ESSA Pharma Inc. (“ESSA” or the “Company”) (NASDAQ:EPIX) in the United States District Court for the Eastern District of Wisconsin on behalf of all persons and entities who purchased or otherwise acquired ESSA securities between December 12, 2023 and October 31, 2024, both dates inclusive (the “Class Period”). Investors have until March 25, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.